We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study

- Parkinson's Disease
- Completed

Study Title: A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.

Teva Identifier: TVP - 1012/133a

ClinicalTrials.gov Identifier: NCT00203125

Study Status: Completed

Trial Condition(s): Parkinson's Disease

Interventions: Drug: rasagiline mesylate | Other: tyramine

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

neurology icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: Child, Adult, Older Adult

Trial Duration: 10/01/2000 - 01/01/2003

Phase: Phase 3

Study Type

Interventional